A Response To: Sodium-Glucose Cotransporter-2 Inhibitors and Major Covid-19 Outcomes: Promising Mechanisms, Conflicting Data And Intriguing Clinical Decisions
media
posted on 2020-10-13, 10:29authored byAntonio C. Bossi, Franco Forloni, Paolo L. Colombelli
There are currently no digital
features for this article. For a full list of declarations, including funding
and author disclosure statements, please see the full text online (see “read
the peer-reviewed publication” opposite).